222 related articles for article (PubMed ID: 24147360)
21. In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1.
Malonne H; Farinelle S; Decaestecker C; Gordower L; Fontaine J; Chaminade F; Saucier JM; Atassi G; Kiss R
Clin Cancer Res; 2000 Sep; 6(9):3774-82. PubMed ID: 10999772
[TBL] [Abstract][Full Text] [Related]
22. Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumour drugs.
Moinet-Hedin V; Tabka T; Poulain L; Godard T; Lechevrel M; Saturnino C; Lancelot JC; Le Talaër JY; Gauduchon P
Anticancer Drug Des; 2000 Apr; 15(2):109-18. PubMed ID: 10901298
[TBL] [Abstract][Full Text] [Related]
23. Antitumor Activity of New Olivacine Derivatives.
Piasny J; Wiatrak B; Dobosz A; Tylińska B; Gębarowski T
Molecules; 2020 May; 25(11):. PubMed ID: 32481577
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and cytotoxic activity of the heptaphylline and 7-methoxyheptaphylline series.
Thongthoom T; Promsuwan P; Yenjai C
Eur J Med Chem; 2011 Sep; 46(9):3755-61. PubMed ID: 21641693
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of indoloquinolines and pyridocarbazoles: a new example of unexpected photoreduction accompanying photocyclization.
Aragon PJ; Yapi AD; Pinguet F; Chezal JM; Teulade JC; Blache Y
Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1349-55. PubMed ID: 17827760
[TBL] [Abstract][Full Text] [Related]
26. DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells.
Poljaková J; Frei E; Gomez JE; Aimová D; Eckschlager T; Hrabeta J; Stiborová M
Cancer Lett; 2007 Jul; 252(2):270-9. PubMed ID: 17306925
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II.
Tylińska B; Dobosz A; Spychała J; Cwynar-Zając Ł; Czyżnikowska Ż; Kuźniarski A; Gębarowski T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445198
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and cytostatic properties of some 6H-Indolo[2, 3-b][1, 8]naphthyridine derivatives.
Mastalarz H; Jasztold-Howorko R; Rulko F; Croisy A; Carrez D
Arch Pharm (Weinheim); 2004 Aug; 337(8):434-9. PubMed ID: 15293262
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2.
Prudent R; Moucadel V; Nguyen CH; Barette C; Schmidt F; Florent JC; Lafanechère L; Sautel CF; Duchemin-Pelletier E; Spreux E; Filhol O; Reiser JB; Cochet C
Cancer Res; 2010 Dec; 70(23):9865-74. PubMed ID: 21118972
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antiproliferative activity of oxazinocarbazole and N,N-bis(carbazolylmethyl)amine derivatives.
Issa S; Walchshofer N; Kassab I; Termoss H; Chamat S; Geahchan A; Bouaziz Z
Eur J Med Chem; 2010 Jun; 45(6):2567-77. PubMed ID: 20236739
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in-vitro antitumor activities of some mannich bases of 9-alkyl-1,2,3,4-tetrahydrocarbazole-1-ones.
Chen J; Lou J; Liu T; Wu R; Dong X; He Q; Yang B; Hu Y
Arch Pharm (Weinheim); 2009 Mar; 342(3):165-72. PubMed ID: 19212985
[TBL] [Abstract][Full Text] [Related]
34. Antineoplastic activity of benzimidazo[1,2-b]-isoquinolines, indolo[2,3-b]quinolines, and pyridocarbazoles.
Weinkauf RL; Chen AY; Yu C; Liu L; Barrows L; LaVoie EJ
Bioorg Med Chem; 1994 Aug; 2(8):781-6. PubMed ID: 7894971
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and preliminary biological evaluation of a new pyridocarbazole derivative covalently linked to a thymidine nucleoside as a potential targeted antitumoral agent. I.
Saturnino C; Buonerba M; Boatto G; Pascale M; Moltedo O; de Napoli L; Montesarchio D; Lancelot JC; de Caprariis P
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):971-4. PubMed ID: 12913238
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of a new class of 2-anilino substituted nicotinyl arylsulfonylhydrazides as potential anticancer and antibacterial agents.
Kamal A; Khan MN; Srinivasa Reddy K; Rohini K
Bioorg Med Chem; 2007 Jan; 15(2):1004-13. PubMed ID: 17097292
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of S-dialkylarsino-3-mercapto-1,2-propanediols and evaluation of their anticancer activity.
Gao M; Tan S; Chen Y; Zingaro RA
Bioorg Med Chem; 2007 Apr; 15(7):2660-6. PubMed ID: 17287125
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues.
Li Q; Zu Y; Shi R; Yao L; Fu Y; Yang Z; Li L
Bioorg Med Chem; 2006 Nov; 14(21):7175-82. PubMed ID: 16870453
[TBL] [Abstract][Full Text] [Related]
40. Antiproliferative activity of some 1,4-dimethylcarbazoles on cells that express estrogen receptors: part I.
Caruso A; Chimento A; El-Kashef H; Lancelot JC; Panno A; Pezzi V; Saturnino C; Sinicropi MS; Sirianni R; Rault S
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):609-13. PubMed ID: 21883039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
